Content
07/15/2024
Richmond, TX USA
Velentium
completed $15 million Series B Round funding. Investors include
Trinity Capital Investment.
About
Velentium is a full-service CDMO with complete in-house capability to design, develop, and manufacture anything from Class II Wearable to Class III Active Implantable Medical Devices. We specialize in active implantables, leads, programmers, and accessories across a wide range of indications, including Neuromodulation, Deep Brain Stimulation, Cardiac Management, and Diabetes Management. We work with clients in all major markets and at every business stage, ranging from startups seeking seed funding to established Fortune 100 companies.
Our core competencies include:
• CGMP Contract Manufacturing
• Automated Test Systems
• Cybersecurity and Cybersecurity Training
• R&D (Systems Engineering, Electrical, Mechanical, Software, Mobile Apps, Human Factors / Usability)
Visit Velentium.com to explore your next step in medical device development.
Startup
Sector:
MedTech
Manufacturing
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
